X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
4.120
-0.090 (-2.14%)
At close: Apr 28, 2026, 4:00 PM EDT
4.160
+0.040 (0.97%)
Pre-market: Apr 29, 2026, 7:21 AM EDT
X4 Pharmaceuticals Employees
X4 Pharmaceuticals had 45 employees as of December 31, 2025. The number of employees decreased by 98 or -68.53% compared to the previous year.
Employees
45
Change (1Y)
-98
Growth (1Y)
-68.53%
Revenue / Employee
$780,289
Profits / Employee
-$1,759,978
Market Cap
374.59M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| Rocket Pharmaceuticals | 202 |
| Puma Biotechnology | 179 |
| Enanta Pharmaceuticals | 120 |
| Silence Therapeutics | 88 |
| Lineage Cell Therapeutics | 77 |
| Immuneering | 53 |
| Avalo Therapeutics | 33 |
XFOR News
- 27 days ago - X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - X4 Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 weeks ago - X4 Pharmaceuticals Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - X4 Pharmaceuticals to Participate in a Fireside Chat at the Leerink Global Healthcare Conference - GlobeNewsWire
- 2 months ago - X4 Pharmaceuticals Receives Positive Opinion from the EMA CHMP Recommending Approval of Mavorixafor in the EU for WHIM Syndrome - GlobeNewsWire
- 2 months ago - X4 Pharmaceuticals Transcript: Guggenheim Securities Emerging Outlook: Biotech Summit 2026 - Transcripts
- 3 months ago - X4 Pharmaceuticals to Participate in Guggenheim's Emerging Outlook: Biotech Summit 2026 - GlobeNewsWire
- 6 months ago - X4 Pharmaceuticals Transcript: Guggenheim Securities 2nd Annual Healthcare Innovation Conference - Transcripts